Abbott and Google Unite to Revolutionize Glucose Insights with AI
Abbott has partnered with Google to integrate glucose insights from its Lingo biowearable into the Google Health app using artificial intelligence. The partnership will allow users to view glucose trends alongside other health and wellness metrics, enabling personalized recommendations for nutrition, activity, sleep, and recovery. This collaboration is part of a multiyear agreement between the two companies, with integrations expected to roll out in the Google Health app later this year.
The Lingo biowearable uses Abbott's FreeStyle Libre CGM technology platform, which monitors diabetes. By combining glucose insights from Lingo with other health data collected by Google Health, users will gain a more comprehensive view of their metabolic health. The partnership also plans to conduct one of the largest real-world studies on metabolic health to date, analyzing connections between activity, sleep, well-being, and glucose levels.
According to Olivier Ropars, divisional VP of Abbott's Lingo business, 'the biggest challenge in healthcare isn't treating disease, it's helping people stay healthier longer.' He believes that this collaboration will provide unprecedented scale for personalized insights, advancing metabolic health research through new real-world studies. The goal is to help users better understand their bodies and take action before health challenges become conditions.